Stock AXDX ACCELERATE DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-09 pm EDT 		5-day change 1st Jan Change
1.15 USD -1.71% Intraday chart for Accelerate Diagnostics, Inc. -1.71% -70.66%
May. 20 Accelerate Diagnostics, Inc. announced that it has received $4.7 million in funding from Jack W. Schuler Living Trust CI
May. 08 Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Accelerate Diagnostics: Q1 Earnings Snapshot
AQ
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
PR
Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
PR
Accelerate Diagnostics : Failure to Satisfy Listing Rule - Form 8-K
PU
Accelerate Diagnostics : Announces 510(k) Submission of the Accelerate Arc™ System to the FDA
PU
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
PR
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results
AQ
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
PR
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
PR
Accelerate Diagnostics Announces Launch of Proposed Public Offering
PR
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
PR
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination with Bruker's MALDI Biotyper
AQ
Accelerate Diagnostics: Q3 Earnings Snapshot
AQ
Accelerate Diagnostics Reports Third Quarter 2023 Results
PR
Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results
AQ
Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.
PR
Accelerate Diagnostics: Q2 Earnings Snapshot
AQ
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results
PR
Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results
PR
Accelerate Diagnostics : Modification to Rights of Security Holders - Form 8-K
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AXDX Stock
  4. News Accelerate Diagnostics, Inc.
  5. Press Releases